These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
81 related articles for article (PubMed ID: 1556957)
1. In vitro production of HIV-1 specific antibodies from "at risk" seronegative subjects. Quarto M; Fiore JR; Chironna M; Fontana A; Germinario C; Troiano T; Fico C; Congedo P; Grottola A; Monno L Microbiologica; 1992 Jan; 15(1):29-33. PubMed ID: 1556957 [TBL] [Abstract][Full Text] [Related]
2. Pokeweed mitogen-stimulated peripheral blood mononuclear cells from at-risk seronegative subjects produce in vitro HIV-1-specific antibodies. Fiore JR; Angarano G; Fico C; Quarto M; Congedo P; di Stefano M; Grottola A; Monno L; Germinario C; Fontana A AIDS; 1991 Aug; 5(8):1034-6. PubMed ID: 1777168 [No Abstract] [Full Text] [Related]
3. Resistance to infection by HIV-1 of peripheral blood mononuclear cells from HIV-1-infected patients is probably mediated by neutralizing antibodies. Tremblay M; Numazaki K; Li XG; Gornitsky M; Hiscott J; Wainberg MA J Immunol; 1990 Nov; 145(9):2896-901. PubMed ID: 1698866 [TBL] [Abstract][Full Text] [Related]
4. HIV-1 isolation from small amounts of whole blood: a technical evaluation. Fiore JR; Angarano G; Fico C; Di Stefano M; Grottola A; Monno L; Fracasso C; Pastore G Microbiologica; 1992 Jan; 15(1):35-44. PubMed ID: 1556958 [TBL] [Abstract][Full Text] [Related]
5. Detection of HIV p24 from antigen presenting monocytes for early diagnosis of HIV-1 infection. Pugliese A; Savarino A; Cantamessa C; Bernengo MG Panminerva Med; 1997 Sep; 39(3):159-64. PubMed ID: 9360414 [TBL] [Abstract][Full Text] [Related]
6. Evaluation of a new dot blot assay for confirmation of human immunodeficiency virus type 1 and 2 infections using recombinant p24, gp41, gp120 and gp36 antigens. Ravanshad M; Sabahi F; Mahboudi F; Kazemnejad A Saudi Med J; 2006 Jan; 27(1):31-6. PubMed ID: 16432590 [TBL] [Abstract][Full Text] [Related]
7. Kinetics of p24 antigenemia, IgM, IgG antibodies to p24 and p41 and Ig virus isolation in rabbits experimentally infected with HIV-1. Filice G; Cereda PM; Orsolini P; Soldini L; Romero E; Rondanelli EG Microbiologica; 1990 Jul; 13(3):215-24. PubMed ID: 2125683 [TBL] [Abstract][Full Text] [Related]
8. [The evidence of human immunodeficiency virus infection in the seronegative subjects of high-risk groups]. Soriano V; Hewlett I; Tor J; Esteve M; Granada I; Muga R; Epstein J; Medrano L Med Clin (Barc); 1991 Oct; 97(12):441-5. PubMed ID: 1753812 [TBL] [Abstract][Full Text] [Related]
9. Specificity of binding of HIV-1 anti-p24 antibodies to CD4+ lymphocytes from HIV-infected subjects. Cameron PU; Hunter SD; Jolley D; Sonza S; Mijch A; Crowe SM Cytometry; 1998 Sep; 33(1):83-8. PubMed ID: 9725562 [TBL] [Abstract][Full Text] [Related]
10. [Early diagnosis of primary HIV infections: using a combined screening test (p24 antigen and anti-HIV antibodies)]. Yerly S; Simon F; Perrin L Schweiz Med Wochenschr; 1999 Feb; 129(8):319-22. PubMed ID: 10189669 [TBL] [Abstract][Full Text] [Related]
11. HIV type 1-specific IgE in serum of long-term surviving children inhibits HIV type 1 production in vitro. Pellegrino MG; Bluth MH; Smith-Norowitz T; Fikrig S; Volsky DJ; Moallem H; Auci DL; Nowakowski M; Durkin HG AIDS Res Hum Retroviruses; 2002 Mar; 18(5):363-72. PubMed ID: 11897038 [TBL] [Abstract][Full Text] [Related]
12. Measurement of HIV-1 p24 antigen by signal-amplification-boosted ELISA of heat-denatured plasma is a simple and inexpensive alternative to tests for viral RNA. Schüpbach J AIDS Rev; 2002; 4(2):83-92. PubMed ID: 12152521 [TBL] [Abstract][Full Text] [Related]
13. [Virological diagnosis and follow-up of HIV infection. State of the art and situation in Tunisia]. Ben Mamou M; Slim A; Garbouj M; Ben Redjeb S Tunis Med; 2006 Jul; 84(7):395-402. PubMed ID: 17039728 [TBL] [Abstract][Full Text] [Related]
14. P24 antigen detection, viral isolation, DNA-PCR and in vitro antibody production for the diagnosis of HIV-1 latent infection in heterosexual women at high risk for HIV-1 infection. Di Stefano M; Fiore JR; Chironna M; Buccoliero G; Romanelli C; La Grasta L; Quarto M; Angarano G; Pastore G Genitourin Med; 1995 Apr; 71(2):123-5. PubMed ID: 7744402 [TBL] [Abstract][Full Text] [Related]
15. Immunization of human HIV-seronegative volunteers with recombinant p17/p24:Ty virus-like particles elicits HIV-1 p24-specific cellular and humoral immune responses. Martin SJ; Vyakarnam A; Cheingsong-Popov R; Callow D; Jones KL; Senior JM; Adams SE; Kingsman AJ; Matear P; Gotch FM AIDS; 1993 Oct; 7(10):1315-23. PubMed ID: 8267904 [TBL] [Abstract][Full Text] [Related]
16. Comparison of HIV-specific CD8 T-cell responses among uninfected individuals exposed to HIV parenterally and mucosally. Makedonas G; Bruneau J; Alary M; Tsoukas CM; Lowndes CM; Lamothe F; Bernard NF AIDS; 2005 Feb; 19(3):251-9. PubMed ID: 15718835 [TBL] [Abstract][Full Text] [Related]
17. Resting cell neutralization assay for HIV-1 primary isolates. Hioe C; Burda S; Chigurupati P; Xu S; Zolla-Pazner S Methods; 1997 Aug; 12(4):300-5. PubMed ID: 9245610 [TBL] [Abstract][Full Text] [Related]